News about "Xuan Linli"

Jiahui International Cancer Centre Stabilizes US Lung Cancer Patient Using China-Developed Immunotherapy Ivonescimab

Jiahui International Cancer Centre Stabilizes US Lung Cancer Patient Using China-Developed Immunotherapy Ivonescimab

Jiahui International Cancer Centre in Shanghai treats a US patient with advanced Non?Small Cell Lung Cancer using Ivonescimab, an experimental immunotherapy currently available only in China.

Xuan Linli | 09/03/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members